0001562180-18-003026.txt : 20180615
0001562180-18-003026.hdr.sgml : 20180615
20180615175310
ACCESSION NUMBER: 0001562180-18-003026
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180615
FILED AS OF DATE: 20180615
DATE AS OF CHANGE: 20180615
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Calcaterra Chris M.
CENTRAL INDEX KEY: 0001640771
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37463
FILM NUMBER: 18903254
MAIL ADDRESS:
STREET 1: C/O GLAUKOS CORPORATION
STREET 2: 26051 MERIT CIRCLE, SUITE 103
CITY: LAGUNA HILLS
STATE: CA
ZIP: 92653
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GLAUKOS Corp
CENTRAL INDEX KEY: 0001192448
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 229 AVENIDA FABRICANTE
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92672
BUSINESS PHONE: 949-367-9600
MAIL ADDRESS:
STREET 1: 229 AVENIDA FABRICANTE
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92672
FORMER COMPANY:
FORMER CONFORMED NAME: GLAUKOS CORP
DATE OF NAME CHANGE: 20020925
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2018-06-15
false
0001192448
GLAUKOS Corp
GKOS
0001640771
Calcaterra Chris M.
C/O GLAUKOS CORPORATION
229 AVENIDA FABRICANTE
SAN CLEMENTE
CA
92672
false
true
false
false
Chief Operating Officer
Common Stock
2018-06-15
4
M
false
8771.00
4.225
A
248771.00
D
Common Stock
2018-06-15
4
S
false
8771.00
44.01
D
240000.00
D
Stock Options (Right to buy)
4.225
2018-06-15
4
M
false
8771.00
0.00
D
2023-01-29
Common Stock
8771.00
9629.00
D
These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices.
This transaction was executed in multiple trades at prices ranging from $44.00 to $44.05. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This option was granted on January 29, 2013, and had a four-year vesting schedule in which 25% vested on the first year anniversary date of the grant and the remainder vested in equal monthly installments for 36 months thereafter, such that the stock option vested in full on the four-year anniversary of the grant date.
/s/ Robert Davis, Attorney-in-Fact
2018-06-15